← Evidence map

ArticleBMC cancer2020

Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.

Andy Göbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32727400